You are here:

NICE
NICE Guidance
Conditions and diseases
Cancer
Head and neck cancers

Cetuximab for the treatment of locally advanced squamous cell cancer of the head and neck

Technology appraisal guidance
Reference number: TA145
Published: 25 June 2008

Guidance
Tools and resources
Information for the public
Evidence
History

Appendix A: provisional matrix of stakeholders

Appendix A: provisional matrix of stakeholders

Appendix A: provisional matrix of stakeholders
11 April 2011
(42.3 Kb 12 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 11 April 2011